As the number of people with osteoarthritis, sports-related knee injuries ... especially in developing countries, is ...

The prevalence of osteoarthritis (OA) is rising in Canada, largely due to an ageing population and higher obesity rates.

Even if you've been diagnosed with RA, your healthcare provider may want to investigate other possible causes if you are not ...

The drug semaglutide, commonly known by the brand names Ozempic or Wegovy, was originally developed to help people with type 2 diabetes manage their ...

A recent study found semaglutide – the drug known as Ozempic – can improve knee pain in people with obesity and ...

"I'm using [Ozempic] off-label for a whole host of conditions — and have been for years," Dr. Caroline Messer, an ...

The results announced today from the fifth cohort of the RESOLVE trial, for treatment of EoE, are derived from 12, 4 mg injections of EP-104GI (total dose of 48 mg) administered to the lower ...

Genascence Corporation ("Genascence"), a clinical-stage biotechnology company revolutionizing the treatment of prevalent ...

Organogenesis (ORGO) announced the favorable outcome of the interim analysis of its second Phase 3 randomized control trial of ReNu, a ...

Weight loss drugs like Ozempic and Wegovy may provide strong relief from severe osteoarthritis knee pain, new research finds.

The Food and Drug Administration (FDA) has granted Fast Track designation to GNSC-001 for the treatment of osteoarthritis of the knee. GNSC-001 is an investigational, adeno-associated virus gene ...

Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and ...